GGrantIndex
← Leaderboards

J Michael McIntosh

Utah State Higher Education System--University Of Utah

$11,017,086
Attributed
$11,017,086
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $767.7K · FY200524
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$11,017,086 · 6

By mechanism

R01$5,987,725 · 2
P01$2,629,280 · 2
R35$2,292,974 · 1
R29$107,107 · 1

Top collaborators

No co-investigators on record.

Most similar at Utah State Higher Education System--University Of Utah

Same institution · by research overlap

Others in their field

Top investigators on “Nicotinic Receptors

Research focus

Nicotinic ReceptorsPeptidesLigandsConus GenusConotoxinParkinson DiseaseVenomsStructureAffinityReceptorBaseNerve InjuryToxinChronic PainMolecularSnailsSourceLaboratoriesCellsSpecificityPharmaceutical PreparationsAlpha-ConotoxinImmuneAcetylcholine

Grant awards (37)

Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical Research$449,875
R35 · FY2024 · GM · contact PI
Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical Research$449,875
R35 · FY2023 · GM · contact PI
Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical Research$449,875
R35 · FY2022 · GM · contact PI
Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical Research$449,875
R35 · FY2021 · GM · contact PI
Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical Research$449,875
R35 · FY2020 · GM · contact PI
Administrative Supplements for Equipment - Purification System$43,599
R35 · FY2020 · GM · contact PI
Novel nAChR-Targeted Peptides$425,262
R01 · FY2019 · GM · contact PI
Novel nAChR-Targeted Peptides$406,835
R01 · FY2018 · GM · contact PI
Project II- Alpha9* Nicotinic Acetylcholine Receptors$279,481
P01 · FY2018 · GM · contact PI
Novel nAChR-Targeted Peptides$67,523
R01 · FY2018 · GM · contact PI
Novel nAChR-Targeted Peptides$394,820
R01 · FY2017 · GM · contact PI
Project II- Alpha9* Nicotinic Acetylcholine Receptors$279,481
P01 · FY2017 · GM · contact PI
Novel nAChR-Targeted Peptides$348,341
R01 · FY2016 · GM · contact PI
Project II- Alpha9* Nicotinic Acetylcholine Receptors$281,053
P01 · FY2016 · GM · contact PI
Project II- Alpha9* Nicotinic Acetylcholine Receptors$289,319
P01 · FY2015 · GM · contact PI
Project II- Alpha9* Nicotinic Acetylcholine Receptors$279,481
P01 · FY2014 · GM · contact PI
Novel nAChR-Targeted Peptides$343,888
R01 · FY2013 · GM · contact PI
Novel nAChR-Targeted Peptides$373,646
R01 · FY2012 · GM · contact PI
Alpha-Conotoxin - alpha9_alpha10 nAChRs$242,503
P01 · FY2012 · GM · contact PI
Novel nAChR-Targeted Peptides$519,551
R01 · FY2011 · MH · contact PI
Alpha-Conotoxin - alpha9_alpha10 nAChRs$248,136
P01 · FY2011 · GM · contact PI
Novel Neuronal nAChR-Targeted Peptides$308,475
R01 · FY2010 · MH · contact PI
Alpha-Conotoxin - alpha9_alpha10 nAChRs$247,848
P01 · FY2010 · GM · contact PI
Novel Neuronal nAChR-Targeted Peptides$308,475
R01 · FY2009 · MH · contact PI
Alpha-Conotoxin - alpha9_alpha10 nAChRs$243,375
P01 · FY2009 · GM · contact PI
Novel Neuronal nAChR-Targeted Peptides$43,660
R01 · FY2009 · MH · contact PI
Novel Neuronal nAChR-Targeted Peptides$308,475
R01 · FY2008 · MH · contact PI
Alpha-Conotoxin - alpha9_alpha10 nAChRs$238,603
P01 · FY2008 · GM · contact PI
Novel Neuronal nAChR-Targeted Peptides$308,475
R01 · FY2007 · MH · contact PI
Novel Neuronal nAChR-Targeted Peptides$50,277
R01 · FY2007 · MH · contact PI
Novel Neuronal nAChR-Targeted Peptides$317,688
R01 · FY2006 · MH · contact PI
Novel Neuronal nAChR-Targeted Peptides$262,500
R01 · FY2005 · MH
Novel Neuronal nAChR-Targeted Peptides$300,000
R01 · FY2004 · MH
Novel Neuronal nAChR-Targeted Peptides$300,000
R01 · FY2003 · MH
Novel Neuronal nAChR-Targeted Peptides$300,000
R01 · FY2002 · MH
Novel Neuronal nAChR-Targeted Peptides$299,834
R01 · FY2001 · MH
NOVEL NEURONAL NACHR-TARGETED PEPTIDES$107,107
R29 · FY2000 · MH